Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Noradrenergic and serotoninergic depression?

O Yazici¹, F Aricioğlu, G Gürvit

¹Department of Psychiatry, Istanbul Medical Faculty, University of Istanbul, Turkey.

Journal of Affective Disorders

|February 1, 1993

Summary

This study investigated noradrenergic and serotoninergic subtypes of depression using urinary MHPG, DST, and antidepressant response. Results found no correlation, failing to support the subtype hypothesis, but noted decreased MHPG during treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Novel preoperative computed tomography (CT)-derived parameters to enhance self-expanding metallic stents (SEMS) outcomes in obstructive colorectal cancer.

Clinical radiology·2025

Same author

Extranodal Nasal-Type NK/T-Cell Lymphoma Treatment: Analysis from a Multicenter Study.

Nigerian journal of clinical practice·2025

Same author

Pembrolizumab plus enzalutamide and androgen deprivation therapy versus placebo plus enzalutamide and androgen deprivation therapy for metastatic hormone-sensitive prostate cancer: the randomized, double-blind, phase III KEYNOTE-991 study.

Annals of oncology : official journal of the European Society for Medical Oncology·2025

Same author

Osimertinib after definitive chemoradiotherapy in unresectable stage III epidermal growth factor receptor-mutated non-small-cell lung cancer: analyses of central nervous system efficacy and distant progression from the phase III LAURA study.

Annals of oncology : official journal of the European Society for Medical Oncology·2024

Same author

Resilience to periodic disturbances and the long-term genetic stability in Acropora coral.

Communications biology·2024

Same author

Safety and efficacy of nivolumab therapy in patients with metastatic renal cell carcinoma and impaired kidney function.

Actas urologicas espanolas·2024

Area of Science:

Neuroscience
Psychiatry
Pharmacology

Background:

Depression is a complex mood disorder with proposed subtypes.
Noradrenergic and serotoninergic systems are implicated in depression.
Previous research suggests distinct biological markers for depressive subtypes.

Purpose of the Study:

To test the hypothesis of distinct noradrenergic and serotoninergic depressive subtypes.
To investigate correlations between urinary MHPG, DST, and clinical response to specific antidepressants.
To determine if biological markers predict treatment response in depression.

Main Methods:

Measured urinary 3-methoxy-4-hydroxyphenylglycol (MHPG) levels.
Administered the dexamethasone suppression test (DST).

Related Experiment Videos

Assessed clinical response to clomipramine and maprotiline, which selectively affect noradrenaline (NA) and 5-hydroxytryptamine (5HT) uptake.

Main Results:

No significant correlation was found between MHPG, DST, and antidepressant response profiles.
The hypothesis of noradrenergic and serotoninergic depressive subtypes was not supported by the data.
A significant decrease in MHPG excretion was observed during antidepressant treatment in patients with high baseline MHPG.

Conclusions:

The study did not find evidence for distinct noradrenergic or serotoninergic subtypes of depression based on the investigated markers.
Urinary MHPG levels may decrease during antidepressant therapy, irrespective of subtype classification.
Further research is needed to elucidate the biological underpinnings and potential subtypes of depression.